BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16585408)

  • 1. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity.
    Seasholtz TM; Wessel J; Rao F; Rana BK; Khandrika S; Kennedy BP; Lillie EO; Ziegler MG; Smith DW; Schork NJ; Brown JH; O'Connor DT
    Hypertension; 2006 May; 47(5):937-47. PubMed ID: 16585408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
    Wang L; Rao F; Zhang K; Mahata M; Rodriguez-Flores JL; Fung MM; Waalen J; Cockburn MG; Hamilton BA; Mahata SK; O'Connor DT
    J Am Coll Cardiol; 2009 Sep; 54(10):944-54. PubMed ID: 19712806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms and haplotype of ROCK2 associate with high altitude essential hypertension in native high altitude Ladakhi Indian population: a preliminary study.
    Pandey P; Mohammad G; Singh Y; Pasha MA
    Clin Exp Hypertens; 2016; 38(2):238-44. PubMed ID: 26818475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins.
    Zhang L; Rao F; Wessel J; Kennedy BP; Rana BK; Taupenot L; Lillie EO; Cockburn M; Schork NJ; Ziegler MG; O'Connor DT
    Physiol Genomics; 2004 Nov; 19(3):277-91. PubMed ID: 15367723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.
    Zhang K; Rao F; Miramontes-Gonzalez JP; Hightower CM; Vaught B; Chen Y; Greenwood TA; Schork AJ; Wang L; Mahata M; Stridsberg M; Khandrika S; Biswas N; Fung MM; Waalen J; Middelberg RP; Heath AC; Montgomery GW; Martin NG; Whitfield JB; Baker DG; Schork NJ; Nievergelt CM; O'Connor DT
    J Am Coll Cardiol; 2012 Oct; 60(17):1678-89. PubMed ID: 23021333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.
    Wessel J; Moratorio G; Rao F; Mahata M; Zhang L; Greene W; Rana BK; Kennedy BP; Khandrika S; Huang P; Lillie EO; Shih PA; Smith DW; Wen G; Hamilton BA; Ziegler MG; Witztum JL; Schork NJ; Schmid-Schönbein GW; O'Connor DT
    J Hypertens; 2007 Feb; 25(2):329-43. PubMed ID: 17211240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic implication of a novel thiamine transporter in human hypertension.
    Zhang K; Huentelman MJ; Rao F; Sun EI; Corneveaux JJ; Schork AJ; Wei Z; Waalen J; Miramontes-Gonzalez JP; Hightower CM; Maihofer AX; Mahata M; Pastinen T; Ehret GB; ; Schork NJ; Eskin E; Nievergelt CM; Saier MH; O'Connor DT
    J Am Coll Cardiol; 2014 Apr; 63(15):1542-55. PubMed ID: 24509276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
    Donner KM; Hiltunen TP; Hannila-Handelberg T; Suonsyrjä T; Kontula K
    Hypertens Res; 2012 Jan; 35(1):107-14. PubMed ID: 21993215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.
    Chen Y; Rao F; Rodriguez-Flores JL; Mahata M; Fung MM; Stridsberg M; Vaingankar SM; Wen G; Salem RM; Das M; Cockburn MG; Schork NJ; Ziegler MG; Hamilton BA; Mahata SK; Taupenot L; O'Connor DT
    J Am Coll Cardiol; 2008 Oct; 52(18):1468-81. PubMed ID: 19017515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.
    Newton-Cheh C; Guo CY; Gona P; Larson MG; Benjamin EJ; Wang TJ; Kathiresan S; O'Donnell CJ; Musone SL; Camargo AL; Drake JA; Levy D; Hirschhorn JN; Vasan RS
    Hypertension; 2007 Apr; 49(4):846-56. PubMed ID: 17296870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
    Schwartz GL; Turner ST; Chapman AB; Boerwinkle E
    Kidney Int; 2002 Nov; 62(5):1718-23. PubMed ID: 12371972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels.
    Schunkert H; Hense HW; Döring A; Riegger GA; Siffert W
    Hypertension; 1998 Sep; 32(3):510-3. PubMed ID: 9740618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic polymorphism and the human stress response.
    Rao F; Zhang L; Wessel J; Zhang K; Wen G; Kennedy BP; Rana BK; Das M; Rodriguez-Flores JL; Smith DW; Cadman PE; Salem RM; Mahata SK; Schork NJ; Taupenot L; Ziegler MG; O'Connor DT
    Ann N Y Acad Sci; 2008 Dec; 1148():282-96. PubMed ID: 19120120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic and hemodynamic origins of pre-hypertension: central role of heredity.
    Davis JT; Rao F; Naqshbandi D; Fung MM; Zhang K; Schork AJ; Nievergelt CM; Ziegler MG; O'Connor DT
    J Am Coll Cardiol; 2012 Jun; 59(24):2206-16. PubMed ID: 22676942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic influences on blood pressure response to the cold pressor test: results from the Heredity and Phenotype Intervention Heart Study.
    Roy-Gagnon MH; Weir MR; Sorkin JD; Ryan KA; Sack PA; Hines S; Bielak LF; Peyser PA; Post W; Mitchell BD; Shuldiner AR; Douglas JA
    J Hypertens; 2008 Apr; 26(4):729-36. PubMed ID: 18327083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.
    Rao F; Chiron S; Wei Z; Fung MM; Chen Y; Wen G; Khandrika S; Ziegler MG; Benyamin B; Montgomery G; Whitfield JB; Martin NG; Waalen J; Hamilton BA; Mahata SK; O'Connor DT
    Am J Hypertens; 2012 Jan; 25(1):29-40. PubMed ID: 21918574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
    Resnick LM; Catanzaro D; Sealey JE; Laragh JH
    Am J Hypertens; 2004 Mar; 17(3):203-8. PubMed ID: 15001191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any association between childhood cardiac septal defects and ROCK2 gene polymorphism?
    Aksoy M; Uygun H; Baspinar O; Demiryurek S; Oztuzcu S; Cengiz B; Irdem A; Araz NC
    Genet Mol Res; 2014 Mar; 13(1):1949-54. PubMed ID: 24668682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
    Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
    Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.